Successful Settlement with HHS-OIG on Behalf of a Private Equity Backed Portfolio Provider

We successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to the Department of Health and Human Services Office of Inspector General (HHS-OIG) involving improper billing. Our team conducted an internal investigation into possible compliance issues, drafted the disclosure to HHS-OIG, and negotiated the final settlement between the parties resulting in a favorable resolution.

You Also May Be Interested In:

  • Represented TVV Capital portfolio company Big 3 Precision Products, Inc., a maker of turnkey packaging solutions, in its sale to The Eastern Company (Nasdaq: EML), a publicly traded diversified manufacturer, for $81.7 million

    We represented TVV Capital portfolio company Big 3 Precision Products, Inc., a maker of turnkey packaging solutions, in its sale...
    Client Type: Private Company
  • We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.

     

    We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc.,...
    Client Type: Public Company
  • We represented Verdi Oncology, Inc. in its acquisition of NexGen Oncology. With the acquisition of NexGen, Verdi has launched Verdi...
    Client Type: Private Company